Literature DB >> 18415691

Akt1 is necessary for the vascular maturation and angiogenesis during cutaneous wound healing.

Payaningal R Somanath1, Juhua Chen, Tatiana V Byzova.   

Abstract

Previous in vivo and in vitro studies have shown that Akt1 serves as a crucial regulator of vascular maturation, extracellular matrix composition, and angiogenesis in tumors. Hence, we hypothesized that Akt1 may be necessary for other angiogenesis-dependent processes, including wound healing. Using Akt1 (-/-) and Akt2 (-/-) mice, we demonstrate that deficiency of Akt1, but not Akt2, results in impaired assembly of collagen in skin wounds and around the blood vessels. Wounds in Akt1 (-/-) mice, but not in Akt2 (-/-) mice, were characterized by reduced vascular area as well as impaired vascular maturation as evidenced by reduced smooth muscle cell recruitment. Expression level of a major angiogenic growth factor, VEGF, was significantly lower in wound tissues of Akt1 (-/-) mice as compared to WT. However, despite the impaired collagen assembly and reduced angiogenesis in Akt1 (-/-) wounds, no significant difference in migration of fibroblasts into the wound area was observed between WT and Akt1 (-/-) mice. Importantly, the dynamics of wound closure were similar between WT, Akt1 (-/-), and Akt2 (-/-) mice. Thus, it appears that although the lack of Akt1 impairs VEGF expression, wound angiogenesis, and subsequent maturation of vasculature, it has no effect on the wound closure. These findings may have clinical applications for the improvement of treatment procedures with reported history of wound healing complications.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18415691      PMCID: PMC2677211          DOI: 10.1007/s10456-008-9111-7

Source DB:  PubMed          Journal:  Angiogenesis        ISSN: 0969-6970            Impact factor:   9.596


  41 in total

Review 1.  Cutaneous wound healing.

Authors:  A J Singer; R A Clark
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

Review 2.  Predicting benefit from anti-angiogenic agents in malignancy.

Authors:  Adrian M Jubb; Adam J Oates; Scott Holden; Hartmut Koeppen
Journal:  Nat Rev Cancer       Date:  2006-07-13       Impact factor: 60.716

Review 3.  Formation and function of the myofibroblast during tissue repair.

Authors:  Boris Hinz
Journal:  J Invest Dermatol       Date:  2007-03       Impact factor: 8.551

Review 4.  Inhibition of PI3K/Akt signaling: an emerging paradigm for targeted cancer therapy.

Authors:  Yulong L Chen; Ping-Y Law; Horace H Loh
Journal:  Curr Med Chem Anticancer Agents       Date:  2005-11

Review 5.  HIFing the brakes: therapeutic opportunities for treatment of human malignancies.

Authors:  Joseph A Garcia
Journal:  Sci STKE       Date:  2006-05-30

6.  Hypoxia-inducible factor-1-dependent and -independent regulation of insulin-like growth factor-1-stimulated vascular endothelial growth factor secretion.

Authors:  Mark G Slomiany; Steven A Rosenzweig
Journal:  J Pharmacol Exp Ther       Date:  2006-05-08       Impact factor: 4.030

7.  Mechanisms underlying TGF-beta1-induced expression of VEGF and Flk-1 in mouse macrophages and their implications for angiogenesis.

Authors:  Seong-Hyun Jeon; Byung-Chul Chae; Hyun-A Kim; Goo-Young Seo; Dong-Wan Seo; Gie-Taek Chun; Nam-Soo Kim; Se-Won Yie; Woo-Hyeon Byeon; Seok-Hyun Eom; Kwon-Soo Ha; Young-Myeong Kim; Pyeung-Hyeun Kim
Journal:  J Leukoc Biol       Date:  2006-10-19       Impact factor: 4.962

Review 8.  Procoagulant microparticles: disrupting the vascular homeostasis equation?

Authors:  Olivier Morel; Florence Toti; Bénédicte Hugel; Babé Bakouboula; Laurence Camoin-Jau; Françoise Dignat-George; Jean-Marie Freyssinet
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-09-21       Impact factor: 8.311

Review 9.  Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway.

Authors:  Ichiro Shiojima; Kenneth Walsh
Journal:  Genes Dev       Date:  2006-12-15       Impact factor: 11.361

10.  Diallyl trisulfide inhibits angiogenic features of human umbilical vein endothelial cells by causing Akt inactivation and down-regulation of VEGF and VEGF-R2.

Authors:  Dong Xiao; Mengfeng Li; Anna Herman-Antosiewicz; Jedrzej Antosiewicz; Hui Xiao; Karen L Lew; Yan Zeng; Stanley W Marynowski; Shivendra V Singh
Journal:  Nutr Cancer       Date:  2006       Impact factor: 2.900

View more
  39 in total

1.  AKT2 maintains brain endothelial claudin-5 expression and selective activation of IR/AKT2/FOXO1-signaling reverses barrier dysfunction.

Authors:  Richard S Beard; Brian A Hoettels; Jamie E Meegan; Travis S Wertz; Byeong J Cha; Xiaoyuan Yang; Julia T Oxford; Mack H Wu; Sarah Y Yuan
Journal:  J Cereb Blood Flow Metab       Date:  2018-12-21       Impact factor: 6.200

2.  Akt1 is critical for acute inflammation and histamine-mediated vascular leakage.

Authors:  Annarita Di Lorenzo; Carlos Fernández-Hernando; Giuseppe Cirino; William C Sessa
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-21       Impact factor: 11.205

3.  p70 S6-kinase mediates the cooperation between Akt1 and Mek1 pathways in fibroblast-mediated extracellular matrix remodeling.

Authors:  Anna Goc; Harika Sabbineni; Maha Abdalla; Payaningal R Somanath
Journal:  Biochim Biophys Acta       Date:  2015-04-02

4.  The Akt inhibitor, triciribine, ameliorates chronic hypoxia-induced vascular pruning and TGFβ-induced pulmonary fibrosis.

Authors:  Maha Abdalla; Harika Sabbineni; Roshini Prakash; Adviye Ergul; Susan C Fagan; Payaningal R Somanath
Journal:  Br J Pharmacol       Date:  2015-07-06       Impact factor: 8.739

5.  Endothelial RAF1/ERK activation regulates arterial morphogenesis.

Authors:  Yong Deng; Bruno Larrivée; Zhen W Zhuang; Deepak Atri; Filipa Moraes; Claudia Prahst; Anne Eichmann; Michael Simons
Journal:  Blood       Date:  2013-03-25       Impact factor: 22.113

6.  Endothelial nitric oxide synthase controls the expression of the angiogenesis inhibitor thrombospondin 2.

Authors:  Susan MacLauchlan; Jun Yu; Marcus Parrish; Tara A Asoulin; Michael Schleicher; Marie M Krady; Jianmin Zeng; Paul L Huang; William C Sessa; Themis R Kyriakides
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-26       Impact factor: 11.205

Review 7.  Effect of tyrosine kinase inhibitors on wound healing and tissue repair: implications for surgery in cancer patients.

Authors:  Devron R Shah; Shamik Dholakia; Rashmi R Shah
Journal:  Drug Saf       Date:  2014-03       Impact factor: 5.606

8.  Amniotic fluid stem cells prevent β-cell injury.

Authors:  Valentina Villani; Anna Milanesi; Sargis Sedrakyan; Stefano Da Sacco; Susanne Angelow; Maria Teresa Conconi; Rosa Di Liddo; Roger De Filippo; Laura Perin
Journal:  Cytotherapy       Date:  2013-11-07       Impact factor: 5.414

9.  14-3-3beta-Rac1-p21 activated kinase signaling regulates Akt1-mediated cytoskeletal organization, lamellipodia formation and fibronectin matrix assembly.

Authors:  Payaningal R Somanath; Tatiana V Byzova
Journal:  J Cell Physiol       Date:  2009-02       Impact factor: 6.384

Review 10.  Angiogenic cytokines in renovascular disease: do they have potential for therapeutic use?

Authors:  Alejandro R Chade; Nicholas Stewart
Journal:  J Am Soc Hypertens       Date:  2013-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.